Stocks in play: Pure Extracts Technologies Corp.

Provided the following corporate update. Our Pemberton, BC facility is fully operational and in daily production and readily able to meet the increasing demand for gummies, vapes and white label products. We are concurrently working towards scalable entry into the US market via a Michigan-based joint venture which proposes to include strategically located equipment and processing operations within the state. We have successfully launched our functional wellness line of products through our Pure Mushrooms branded Amazon direct-to-consumer sales channels in the US and Canada. Regarding our outlook for psychoactive mushroom compounds, we continue to actively move forward with R&D efforts in this area. We are not alone in finding it hard to obtain psychedelic biomass as it is highly regulated by Health Canada with many people reporting that there is little or no product available for R&D purposes. Fortunately, we have entered an agreement with ShroomBloom, a BC-based psychedelic mushroom cultivator, to assist in providing us with ample product for our R&D efforts upon final receipt of their Health Canada approvals. We are also excited to be working with Psyence Group (CSE: PSYG) who offer very strong R&D and production capabilities. Pure Extracts Technologies Corp. shares C.PULL are trading unchanged at $0.38.

Read:

• Schumer: The U.S. Senate Will Soon Act on Cannabis Legalization

• This is Why Major Gold Companies are Racing Into the Golden Triangle